NEXGEL (NXGL) - Pangali EV/EBITDA

The NEXGEL, Inc. (NXGL) price chart demonstrates an EV/EBITDA ratio of 0.00. The business's financial stability relies on the supply of patches and dressings to retailers while maintaining strict monitoring of material costs. The organization generates revenue through the sale of high-efficiency hydrogel products to clinics and pharmacies. Its development vector is aimed at penetrating new medical niches to systematically capture the specialized equipment segment.

The multiple compares the total enterprise value, including net debt, to its operating profit before depreciation and amortization, allowing for an assessment of the real value of assets without the influence of the tax regime. By analyzing the EV/EBITDA ratio of the business, an investor separates the fundamental stability of NEXGEL (NXGL) from market noise, evaluating the efficiency of medical patch production while accounting for environmental control and emission purification costs.